The interferon-gamma (IFN-γ) +874T allele reduces the risk of hepatitis B infection in an Asian population

Journal of Viral Hepatitis

Volumn 21, Issue 4, 2014, Pages 281-287

  Sun, X R ^a   Wu, J ^a   Tang, K F ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

chronic hepatitis B; IFN gamma gene; meta analysis; polymorphism

Indexed keywords

GAMMA INTERFERON;

ALLELE; ARTICLE; ASIAN; CONFIDENCE INTERVAL; DATA EXTRACTION; EMBASE; ETHNICITY; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HEPATITIS B; HUMAN; MEDLINE; META ANALYSIS; PRIORITY JOURNAL;

CHRONIC HEPATITIS B; IFN-GAMMA GENE; META-ANALYSIS; POLYMORPHISM;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; INTERFERON-GAMMA; POLYMORPHISM, GENETIC; RISK;

EID: 84895825479     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12140     Document Type: Article

References (37)

1. McMahon BJ,. The natural history of chronic hepatitis B virus infection. Hepatology 2009; 49 (Suppl. 5): S45-S55.
2. Chu CJ, Lok AS,. Clinical significance of hepatitis B virus genotypes. Hepatology 2002; 35 (5): 1274-1276.
3. Thio CL, Thomas DL, Carrington M,. Chronic viral hepatitis and the human genome. Hepatology 2000; 31 (4): 819-827.
4. Kim WR, Benson JT, Therneau TM, Torgerson HA, Yawn BP, Melton LJ 3rd,. Changing epidemiology of hepatitis B in a U.S. community. Hepatology 2004; 39 (3): 811-816.
5. Liu F, Li B, Wei YG, et al,. IFN-γ+874 A/T polymorphism and cancer risk: an updated analysis based on 32 case-control studies. Cytokine 2011; 56 (2): 200-207.
6. Zheng MH, Xiao DD, Lin XF, et al,. The tumour necrosis factor-a-238A allele increases the risk of chronic HBV infection in European populations. J Viral Hepat 2012; 19 (2): e11-e17.
7. Yang PL, Althage A, Chung J, et al,. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci USA 2010; 107 (2): 798-802.
8. Dunn C, Peppa D, Khanna P, et al,. Temporal analysis of early immune responses in patients with acute hepatitis B virus infection. Gastroenterology 2009; 137 (4): 1289-1300.
9. Pontesilli O, van Nunen AB, van Riel D, et al,. Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha. Liver Intl 2004; 24 (4): 308-315.
10. Romero R, Lavine JE,. Cytokine inhibition of the hepatitis B virus core promoter. Hepatology 1996; 23 (1): 17-23.
11. Phillips S, Chokshi S, Riva A, Evans A, Williams R, Naoumov NV,. CD8 (+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol 2010; 184 (1): 287-295.
12. Kan Q, Li D, Yu Z,. Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes. J Virol Methods 2012; 180 (1-2): 84-90.
13. Wu JF, Hsu HY, Ni YH, Chen HL, Wu TC, Chang MH,. Suppression of furin by interferon-γ and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes. Am J Pathol 2012; 181 (1): 19-25.
14. Saxena R, Chawla YK, Kaur J,. Association of IFN-γ gene polymorphism and levels in HBV related disease chronicity in India. BMC Infect Dis 2012; 12 (Suppl. 1): P27.
15. Ben-Ari Z, Mor E, Papo O, et al,. Cytokine gene polymorphisms in patients infected with hepatitis B virus. Am J Gastroenterol 2003; 98 (1): 144-150.
16. Pravica V, Perrey C, Stevens A, Lee JH, Hutchinson IV,. A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production. Hum Immunol 2000; 61 (9): 863-866.
17. Korachi M, Ceran N, Adaleti R, Nigdelioglu A, Sökmen M,. An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-γ with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C. Int J Infect Dis 2013; 17 (1): 44-49.
18. Pan YP, Fan XH, Qiu MB, et al,. Relationship between IFN-gamma gene polymorphisms and response to chronic HBV patients interferon therapy. Tianjin Med J 2011; 11 (39): 1063-1064.
19. Gao QJ, Liu DW, Zhang SY, Jia M, Wu LH,. Association between IFN-gamma+874 polymorphisms and the clinical outcomes of hepatitis B and/or hepatitis C virus infection. Chin J Epidemiol 2010; 31 (3): 324-328.
20. Arababadi MK, Pourfathollah AA, Jafarzadeh A, et al,. Non-association of IL-12 + 1188 and IFN-gamma+874 polymorphisms with cytokines serum level in occult HBV infected patients. Saudi J Gastroenterol 2011; 17 (1): 30-35.
21. Wu JM, Sun H, Wu KW, et al,. Relationship between IFN-gamma gene polymorphisms and clinical outcomes of hepatitis B virus infection. J Wenzhou Med Coll 2008; 38 (3): 241-244.
22. Basturk B, Karasu Z, Kilic M, Ulukaya S, Boyacioglu S, Oral B,. Association of TNF-a-308 polymorphism with the outcome of hepatitis B virus infection in Turkey. Infect Genet Evol 2008; 8 (1): 20-25.
23. Peng XM, Lei RX, Gu L, Ma HH, Xie QF, Gao ZL,. Influences of MxA gene -88 G/T and IFN-gamma +874 A/T on the natural history of hepatitis B virus infection in an endemic area. Int J Immunogenet 2007; 34 (5): 341-346.
24. Zhang PA, Wu JM, Li Y,. Relationship between genetic polymorphisms of interferon-gamma intron 1+874 site and susceptibility of hepatitis B virus infection. Zhonghua Liu Xing Bing Xue Za Zhi 2006; 27 (1): 41-43.
25. Cheong JY, Cho SW, Chung SG, et al,. Genetic polymorphism of interferon-gamma, interferon-gamma receptor, and interferon regulatory factor-1 genes in patients with hepatitis B virus infection. Biochem Genet 2006; 44 (5-6): 246-255.
26. Gao QJ, Liu DW, Zhang SY, et al,. Polymorphisms of some cytokines and chronic hepatitis B and C virus infection. World J Gastroenterol 2009; 15 (44): 5610-5619.
27. Abbott W, Gane E, Winship I, Munn S, Tukuitonga C,. Polymorphism in intron 1 of the interferon-gamma gene influences both serum immunoglobulin E levels and the risk for chronic hepatitis B virus infection in Polynesians. Immunogenetics 2007; 59 (3): 187-195.
28. Liu M, Cao B, Zhang H, Dai Y, Liu X, Xu C,. Association of interferon-gamma gene haplotype in the Chinese population with hepatitis B virus infection. Immunogenetics 2006; 58 (11): 859-864.
29. Lok AS, McMahon BJ,. Chronic hepatitis B: update 2009. Hepatology 2009; 50 (3): 661-662.
30. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327 (7414): 557-560.
31. Tobias A,. Assessing the influence of a single study in the meta-analysis estimate. Stata Tech Bull 1999; 8: 15-17.
32. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315 (7109): 629-634.
33. Zhong JH, You XM, Gong WF, et al,. Epidermal growth factor gene polymorphism and risk of hepatocellular carcinoma: a meta-analysis. PLoS ONE 2012; 7 (3): e32159.
34. Rossouw M, Nel HJ, Cooke GS, van Helden PD, Hoal EG,. Association between tuberculosis and a polymorphic NF kappa B binding site in the interferon gamma gene. Lancet 2003; 361 (9372): 1871-1872.
35. Fan XP, Zou ZQ, Long B, et al,. Enhanced demethylation of interferon-γ gene promoter in peripheral blood mononuclear cells is associated with acute-on-chronic hepatitis B liver failure. Tohoku J Exp Med 2011; 224 (1): 13-19.
36. Chen J, Wang Y, Wu XJ, Li J, Hou FQ, Wang GQ,. Pegylated interferon α-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B. World J Gastroenterol 2010; 16 (48): 6145-6150.
37. Tang JL,. Selection bias in meta-analyses of gene-disease associations. PLoS Med 2005; 2 (12): e409.